ArticleOncogene2017

RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways.

L Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.